Already weary from the Covid-19 pandemic, governments and businesses are now facing a new public health challenge. Monkeypox is spreading rapidly in the United States and globally. Although this infectious disease presents significantly less risk than Covid-19, employers should be prepared to address potential infections in their workforces and communities.
The monkeypox virus is a relative of smallpox and causes systemic symptoms, including fever, swollen lymph nodes, muscle aches, and a characteristic rash that progresses from blisters to pustules. The Jynneos vaccine,…
